Title:  Vinorelbine 
CAS Registry Number:  71486-22-1 
CAS Name:  (2b,3b,4b,5a,12R,19a)-4-(Acetyloxy)-6,7-didehydro-15-[(2R,6R,8S)-4-ethyl-1,3,6,7,8,9-hexahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino[4,3-b]indol-8-yl]-3-hydroxy-16-methoxy-1-methylaspidospermidine-3-carboxylic acid methyl ester 
Additional Names:  3¢,4¢-didehydro-4¢-deoxy-C¢-norvincaleukoblastine;  nor-5¢-anhydrovinblastine;  NVB 
Manufacturers' Codes:  KW-2307 
Molecular Formula:  C45H54N4O8 
Molecular Weight:  778.93 
Percent Composition:  C 69.39%, H 6.99%, N 7.19%, O 16.43% 
Literature References:  Semi-synthetic Vinca alkaloid; structurally related to vinblastine, q.v.  Prepn:  JP Kokai 80 31096; N. Langlois et al., US 4307100 (1980, 1981 both to Agence Nat. Valorisation Recherche); P. Mangeney et al., Tetrahedron 35, 2175 (1979).  Pharmacology:  G. Mathé, P. Reizenstein, Cancer Lett. 27, 285 (1985).  HPLC determn in biological fluids:  F. Jehl et al., J. Chromatogr. 525, 225 (1990).  Veterinary trial in dogs with spontaneous neoplasia:  V. J. Poirier et al., J. Vet. Intern. Med. 18, 536 (2004).  Symposium:  Semin. Oncol. 16, Suppl. 4, 1-45 (1989).  Review of early clinical development:  M. Marty et al., Nouv. Rev. Fr. Hematol. 31, 77-84 (1989); of clinical pharmacokinetics:  D. Leveque, F. Jehl, Clin. Pharmacokinet. 31, 184-197 (1996); of use in advanced non-small cell lung cancer:  M. P. Curran, G. L. Plosker, Drugs Aging 19, 695-721 (2002). 
Properties:  Residue.  [a]D20 +52.4° (c = 0.3 in CHCl3).  uv max (ethanol):  215, 268, 282, 293, 310 nm (e 3700, 11000, 9500, 7600, 4400).  Partition coefficient (octanol/buffer pH 7.2):  16.  LD50 in mice (mg/m2):  72 i.v.; 78 orally (Mathé, Reizenstein). 
Optical Rotation:  [a]D20 +52.4° (c = 0.3 in CHCl3) 
Log P:  Partition coefficient (octanol/buffer pH 7.2):  16 
Absorption maximum:  uv max (ethanol):  215, 268, 282, 293, 310 nm (e 3700, 11000, 9500, 7600, 4400) 
Toxicity data:  LD50 in mice (mg/m2):  72 i.v.; 78 orally (Mathé, Reizenstein) 
  
Derivative Type:  Ditartrate  
CAS Registry Number:  125317-39-7 
Trademarks:  Eunades (Pfizer);  Navelbine (Fabre) 
Molecular Formula:  C45H54N4O8.2C4H6O6 
Molecular Weight:  1079.11 
Percent Composition:  C 58.99%, H 6.16%, N 5.19%, O 29.65% 
Properties:  Yellow-white amorphous powder.  Sol in water and ethanol. 
  
Therap-Cat:  Antineoplastic. 
Therap-Cat-Vet:  Antineoplastic. 
Keywords:  Antineoplastic; Alkaloids/Natural Products; Vinca Alkaloids.   |